A phase I investigation of carboxyamido-triazole (CAI) modulated by ketoconozole in patients with advanced malignancies
Phase of Trial: Phase I
Latest Information Update: 06 Feb 2013
At a glance
- Drugs Ketoconazole (Primary) ; L 651582 (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions
- 21 Sep 2005 New trial record.